Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 256

1.

Building a Citizen Pscientist: Advancing Patient-Centered Psoriasis Research by Empowering Patients as Contributors and Analysts.

Sanchez IM, Shankle L, Wan MT, Afifi L, Wu JJ, Doris F, Bridges A, Boas M, Lafoy B, Truman S, Orbai AM, Takeshita J, Gelfand JM, Armstrong AW, Siegel MP, Liao W.

Dermatol Ther (Heidelb). 2018 Jun 6. doi: 10.1007/s13555-018-0242-5. [Epub ahead of print]

PMID:
29876724
2.

Psoriasis: a novel risk factor for type 2 diabetes.

Gelfand JM, Wan MT.

Lancet Diabetes Endocrinol. 2018 May 21. pii: S2213-8587(18)30127-X. doi: 10.1016/S2213-8587(18)30127-X. [Epub ahead of print] No abstract available.

PMID:
29799414
3.

Distinct HLA associations of LGI1 and CASPR2-antibody diseases.

Binks S, Varley J, Lee W, Makuch M, Elliott K, Gelfand JM, Jacob S, Leite MI, Maddison P, Chen M, Geschwind MD, Grant E, Sen A, Waters P, McCormack M, Cavalleri GL, Barnardo M, Knight JC, Irani SR.

Brain. 2018 May 18. doi: 10.1093/brain/awy109. [Epub ahead of print]

PMID:
29788256
4.

Effect of 2 Psoriasis Treatments on Vascular Inflammation and Novel Inflammatory Cardiovascular Biomarkers: A Randomized Placebo-Controlled Trial.

Mehta NN, Shin DB, Joshi AA, Dey AK, Armstrong AW, Duffin KC, Fuxench ZC, Harrington CL, Hubbard RA, Kalb RE, Menter A, Rader DJ, Reilly MP, Simpson EL, Takeshita J, Torigian DA, Werner TJ, Troxel AB, Tyring SK, Vanderbeek SB, Van Voorhees AS, Playford MP, Ahlman MA, Alavi A, Gelfand JM.

Circ Cardiovasc Imaging. 2018 Jun;11(6):e007394. doi: 10.1161/CIRCIMAGING.117.007394.

PMID:
29776990
5.

Stevens-Johnson Syndrome / Toxic Epidermal Necrolysis: a multicenter retrospective study of 377 adult patients from the United States.

Micheletti RG, Chiesa-Fuxench Z, Noe MH, Stephen S, Aleshin M, Agarwal A, Boggs J, Cardones AR, Chen JK, Cotliar J, Davis MD, Dominguez A, Fox LP, Gordon S, Hamrick R, Ho B, Hughey LC, Jones LM, Kaffenberger BH, Kindley K, Kroshinsky D, Kwong BY, Miller DD, Mostaghimi A, Musiek A, Ortega-Loayza AG, Patel R, Posligua A, Rani M, Saluja S, Sharon VR, Shinkai K, John JS, Strickland N, Summers EM, Sun N, Wanat KA, Wetter DA, Worswick S, Yang C, Margolis DJ, Gelfand JM, Rosenbach M.

J Invest Dermatol. 2018 May 11. pii: S0022-202X(18)31964-X. doi: 10.1016/j.jid.2018.04.027. [Epub ahead of print]

PMID:
29758282
6.

Chronic Meningitis Investigated via Metagenomic Next-Generation Sequencing.

Wilson MR, O'Donovan BD, Gelfand JM, Sample HA, Chow FC, Betjemann JP, Shah MP, Richie MB, Gorman MP, Hajj-Ali RA, Calabrese LH, Zorn KC, Chow ED, Greenlee JE, Blum JH, Green G, Khan LM, Banerji D, Langelier C, Bryson-Cahn C, Harrington W, Lingappa JR, Shanbhag NM, Green AJ, Brew BJ, Soldatos A, Strnad L, Doernberg SB, Jay CA, Douglas V, Josephson SA, DeRisi JL.

JAMA Neurol. 2018 Apr 16. doi: 10.1001/jamaneurol.2018.0463. [Epub ahead of print]

7.

Prospective Cohort Study Investigating Changes in Body Image, Quality of Life, and Self-Esteem Following Minimally Invasive Cosmetic Procedures.

Sobanko JF, Dai J, Gelfand JM, Sarwer DB, Percec I.

Dermatol Surg. 2018 Apr 13. doi: 10.1097/DSS.0000000000001523. [Epub ahead of print]

PMID:
29659404
8.

Sleep disturbance and symptom burden in sarcoidosis.

Benn BS, Lehman Z, Kidd SA, Miaskowski C, Sunwoo BY, Ho M, Sun S, Ramstein J, Gelfand JM, Koth LL.

Respir Med. 2018 Mar 24. pii: S0954-6111(18)30085-4. doi: 10.1016/j.rmed.2018.03.021. [Epub ahead of print]

PMID:
29628134
9.

Commentary: Does biologic treatment of psoriasis lower the risk of cardiovascular events and mortality?: A critical question that we are only just beginning to answer.

Gelfand JM.

J Am Acad Dermatol. 2018 Jul;79(1):69-70. doi: 10.1016/j.jaad.2018.03.046. Epub 2018 Apr 3. No abstract available.

PMID:
29625133
10.

Focal cerebral β-amyloid angiopathy: A distinct clinicopathologic presentation.

Karageorgiou E, Naasan G, Pleasure SJ, Alexandrescu S, Gelfand JM, Tammewar G, Miller BL, Rabinovici GD, Grinberg LT.

Neurol Clin Pract. 2017 Oct;7(5):444-448. doi: 10.1212/CPJ.0000000000000354. No abstract available.

PMID:
29620074
11.

Migraine is common in patients with sarcoidosis.

Gelfand JM, Gelfand AA, Goadsby PJ, Benn BS, Koth LL.

Cephalalgia. 2018 Jan 1:333102418768037. doi: 10.1177/0333102418768037. [Epub ahead of print]

PMID:
29580067
12.

Rituximab before and during pregnancy: A systematic review, and a case series in MS and NMOSD.

Das G, Damotte V, Gelfand JM, Bevan C, Cree BAC, Do L, Green AJ, Hauser SL, Bove R.

Neurol Neuroimmunol Neuroinflamm. 2018 Mar 19;5(3):e453. doi: 10.1212/NXI.0000000000000453. eCollection 2018 May.

13.

The state of clinical research in neurology.

Hall DA, Ramos AR, Gelfand JM, Videnovic A, Benatar M, Cahill C, Kluger BM, Goldman M.

Neurology. 2018 Apr 10;90(15):e1347-e1354. doi: 10.1212/WNL.0000000000005295. Epub 2018 Mar 16.

PMID:
29549220
14.

Reduced contrast sensitivity among older women is associated with increased risk of cognitive impairment.

Ward ME, Gelfand JM, Lui LY, Ou Y, Green AJ, Stone K, Pedula KL, Cummings SR, Yaffe K.

Ann Neurol. 2018 Apr;83(4):730-738. doi: 10.1002/ana.25196. Epub 2018 Apr 11.

PMID:
29518257
15.

Risk of Serious Infection, Opportunistic Infection, and Herpes Zoster among Patients with Psoriasis in the United Kingdom.

Takeshita J, Shin DB, Ogdie A, Gelfand JM.

J Invest Dermatol. 2018 Mar 2. pii: S0022-202X(18)30153-2. doi: 10.1016/j.jid.2018.01.039. [Epub ahead of print]

PMID:
29505759
16.

Research Techniques Made Simple: Pharmacoepidemiology Research Methods in Dermatology.

Noe MH, Gelfand JM.

J Invest Dermatol. 2018 Feb;138(2):e13-e18. doi: 10.1016/j.jid.2017.10.026.

PMID:
29389330
17.

Chronic skin inflammation accelerates macrophage cholesterol crystal formation and atherosclerosis.

Baumer Y, Ng Q, Sanda GE, Dey AK, Teague HL, Sorokin AV, Dagur PK, Silverman JI, Harrington CL, Rodante JA, Rose SM, Varghese NJ, Belur AD, Goyal A, Gelfand JM, Springer DA, Bleck CK, Thomas CL, Yu ZX, Winge MC, Kruth HS, Marinkovich MP, Joshi AA, Playford MP, Mehta NN.

JCI Insight. 2018 Jan 11;3(1). pii: 97179. doi: 10.1172/jci.insight.97179. [Epub ahead of print]

18.

Harnessing electronic medical records to advance research on multiple sclerosis.

Damotte V, Lizée A, Tremblay M, Agrawal A, Khankhanian P, Santaniello A, Gomez R, Lincoln R, Tang W, Chen T, Lee N, Villoslada P, Hollenbach JA, Bevan CD, Graves J, Bove R, Goodin DS, Green AJ, Baranzini SE, Cree BA, Henry RG, Hauser SL, Gelfand JM, Gourraud PA.

Mult Scler. 2018 Jan 1:1352458517747407. doi: 10.1177/1352458517747407. [Epub ahead of print]

PMID:
29310490
19.

Pleocytosis is not fully responsible for low CSF glucose in meningitis.

Baud MO, Vitt JR, Robbins NM, Wabl R, Wilson MR, Chow FC, Gelfand JM, Josephson SA, Miller S.

Neurol Neuroimmunol Neuroinflamm. 2017 Dec 22;5(1):e425. doi: 10.1212/NXI.0000000000000425. eCollection 2018 Jan.

20.

The importance of early immunotherapy in patients with faciobrachial dystonic seizures.

Thompson J, Bi M, Murchison AG, Makuch M, Bien CG, Chu K, Farooque P, Gelfand JM, Geschwind MD, Hirsch LJ, Somerville E, Lang B, Vincent A, Leite MI, Waters P, Irani SR; Faciobrachial Dystonic Seizures Study Group .

Brain. 2018 Feb 1;141(2):348-356. doi: 10.1093/brain/awx323.

21.

Health care utilization for psoriasis in the United States differs by race: An analysis of the 2001-2013 Medical Expenditure Panel Surveys.

Fischer AH, Shin DB, Gelfand JM, Takeshita J.

J Am Acad Dermatol. 2018 Jan;78(1):200-203. doi: 10.1016/j.jaad.2017.07.052. No abstract available.

PMID:
29241786
22.

Psoriasis and the risk of diabetes: A prospective population-based cohort study.

Wan MT, Shin DB, Hubbard RA, Noe MH, Mehta NN, Gelfand JM.

J Am Acad Dermatol. 2018 Feb;78(2):315-322.e1. doi: 10.1016/j.jaad.2017.10.050. Epub 2017 Nov 8.

PMID:
29128465
23.

Risk of Incident Liver Disease in Patients with Psoriasis, Psoriatic Arthritis, and Rheumatoid Arthritis: A Population-Based Study.

Ogdie A, Grewal SK, Noe MH, Shin DB, Takeshita J, Chiesa Fuxench ZC, Carr RM, Gelfand JM.

J Invest Dermatol. 2018 Apr;138(4):760-767. doi: 10.1016/j.jid.2017.10.024. Epub 2017 Nov 2.

PMID:
29104161
24.

Smoking paradox in the development of psoriatic arthritis among patients with psoriasis: a population-based study.

Nguyen UDT, Zhang Y, Lu N, Louie-Gao Q, Niu J, Ogdie A, Gelfand JM, LaValley MP, Dubreuil M, Sparks JA, Karlson EW, Choi HK.

Ann Rheum Dis. 2018 Jan;77(1):119-123. doi: 10.1136/annrheumdis-2017-211625. Epub 2017 Nov 4.

PMID:
29102956
25.

Visceral Adiposity in Psoriasis is Associated With Vascular Inflammation by 18F-Fluorodeoxyglucose Positron-Emission Tomography/Computed Tomography Beyond Cardiometabolic Disease Risk Factors in an Observational Cohort Study.

Rivers JP, Powell-Wiley TM, Dey AK, Rodante JA, Chung JH, Joshi AA, Natarajan B, Sajja AP, Chaturvedi A, Rana A, Harrington CL, Teague HL, Lockshin BN, Ahlman MA, Yao J, Playford MP, Gelfand JM, Mehta NN.

JACC Cardiovasc Imaging. 2018 Feb;11(2 Pt 2):349-357. doi: 10.1016/j.jcmg.2017.08.014. Epub 2017 Oct 18.

PMID:
29055628
26.

Demystifying Neurosarcoidosis and Informing Prognosis.

Gelfand JM.

JAMA Neurol. 2017 Nov 1;74(11):1296-1298. doi: 10.1001/jamaneurol.2017.1473. No abstract available.

PMID:
29052731
27.

Infliximab for the treatment of CNS sarcoidosis: A multi-institutional series.

Gelfand JM, Bradshaw MJ, Stern BJ, Clifford DB, Wang Y, Cho TA, Koth LL, Hauser SL, Dierkhising J, Vu N, Sriram S, Moses H, Bagnato F, Kaufmann JA, Ammah DJ, Yohannes TH, Hamblin MJ, Venna N, Green AJ, Pawate S.

Neurology. 2017 Nov 14;89(20):2092-2100. doi: 10.1212/WNL.0000000000004644. Epub 2017 Oct 13.

PMID:
29030454
28.

Clemastine fumarate as a remyelinating therapy for multiple sclerosis (ReBUILD): a randomised, controlled, double-blind, crossover trial.

Green AJ, Gelfand JM, Cree BA, Bevan C, Boscardin WJ, Mei F, Inman J, Arnow S, Devereux M, Abounasr A, Nobuta H, Zhu A, Friessen M, Gerona R, von Büdingen HC, Henry RG, Hauser SL, Chan JR.

Lancet. 2017 Dec 2;390(10111):2481-2489. doi: 10.1016/S0140-6736(17)32346-2. Epub 2017 Oct 10.

29.

The burden of atopic dermatitis in US adults: Health care resource utilization data from the 2013 National Health and Wellness Survey.

Eckert L, Gupta S, Amand C, Gadkari A, Mahajan P, Gelfand JM.

J Am Acad Dermatol. 2018 Jan;78(1):54-61.e1. doi: 10.1016/j.jaad.2017.08.002. Epub 2017 Oct 7.

30.

Clinical and imaging correlation in patients with pathologically confirmed tumefactive demyelinating lesions.

Tremblay MA, Villanueva-Meyer JE, Cha S, Tihan T, Gelfand JM.

J Neurol Sci. 2017 Oct 15;381:83-87. doi: 10.1016/j.jns.2017.08.015. Epub 2017 Aug 10.

PMID:
28991721
31.

Reply to: "Statistical and methodological issues".

Shin TM, Shaikh WR, Etzkorn JR, Sobanko JF, Margolis DJ, Gelfand JM, Chu EY, Elenitsas R, Miller CJ.

J Am Acad Dermatol. 2017 Oct;77(4):e115-e116. doi: 10.1016/j.jaad.2017.05.030. No abstract available.

PMID:
28917479
32.

Unraveling Vascular Inflammation: From Immunology to Imaging.

Teague HL, Ahlman MA, Alavi A, Wagner DD, Lichtman AH, Nahrendorf M, Swirski FK, Nestle F, Gelfand JM, Kaplan MJ, Grinspoon S, Ridker PM, Newby DE, Tawakol A, Fayad ZA, Mehta NN.

J Am Coll Cardiol. 2017 Sep 12;70(11):1403-1412. doi: 10.1016/j.jacc.2017.07.750. Review.

PMID:
28882238
33.

Objective Measures of Psoriasis Severity Predict Mortality: A Prospective Population-Based Cohort Study.

Noe MH, Shin DB, Wan MT, Gelfand JM.

J Invest Dermatol. 2018 Jan;138(1):228-230. doi: 10.1016/j.jid.2017.07.841. Epub 2017 Aug 23. No abstract available. Erratum in: J Invest Dermatol. 2018 Apr;138(4):998.

PMID:
28843488
34.

The relationship between duration of psoriasis, vascular inflammation, and cardiovascular events.

Egeberg A, Skov L, Joshi AA, Mallbris L, Gislason GH, Wu JJ, Rodante J, Lerman JB, Ahlman MA, Gelfand JM, Mehta NN.

J Am Acad Dermatol. 2017 Oct;77(4):650-656.e3. doi: 10.1016/j.jaad.2017.06.028. Epub 2017 Aug 18.

PMID:
28826925
35.

National Psoriasis Foundation Priorities for Patient-Centered Research: Proceedings from the 2016 Conference.

Afifi L, Shankle L, Armstrong AW, Boas M, Bridges A, Chiguil V, Doris F, Callis Duffin K, Fielding E, Fleischmann R, Gelfand JM, Kiselica M, Kiselica C, LaFoy B, Latella JJ, Takeshita J, Truman S, Wan MT, Wilkerson V, Wu JJ, Siegel MP, Liao W.

J Psoriasis Psoriatic Arthritis. 2017 Summer;2(3):73-80.

36.

Variations in risk of asthma and seasonal allergies between early- and late-onset pediatric atopic dermatitis: A cohort study.

Wan J, Mitra N, Hoffstad OJ, Gelfand JM, Yan AC, Margolis DJ.

J Am Acad Dermatol. 2017 Oct;77(4):634-640. doi: 10.1016/j.jaad.2017.06.013. Epub 2017 Aug 14.

PMID:
28818439
37.

How similar are the treatment responses to biosimilars in patients with psoriasis? A systematic review of statistical margins in comparative clinical trials.

Wan MT, Strober BE, Wu JJ, Shin DB, Gelfand JM.

J Am Acad Dermatol. 2017 Sep;77(3):569-572. doi: 10.1016/j.jaad.2017.05.032. Review. No abstract available.

PMID:
28807110
38.

Clinical and Biological Insights from the University of California San Francisco Prospective and Longitudinal Cohort.

Benn BS, Lehman Z, Kidd SA, Ho M, Sun S, Ramstein J, Arger NK, Nguyen CP, Su R, Gomez A, Gelfand JM, Koth LL.

Lung. 2017 Oct;195(5):553-561. doi: 10.1007/s00408-017-0037-y. Epub 2017 Jul 13.

PMID:
28707108
39.

Ocrelizumab and Other CD20+ B-Cell-Depleting Therapies in Multiple Sclerosis.

Gelfand JM, Cree BAC, Hauser SL.

Neurotherapeutics. 2017 Oct;14(4):835-841. doi: 10.1007/s13311-017-0557-4. Review.

PMID:
28695471
40.

Patterns and predictors of atopic dermatitis disease control past childhood: An observational cohort study.

Abuabara K, Hoffstad O, Troxel AB, Gelfand JM, McCulloch CE, Margolis DJ.

J Allergy Clin Immunol. 2018 Feb;141(2):778-780.e6. doi: 10.1016/j.jaci.2017.05.031. Epub 2017 Jun 17. No abstract available.

PMID:
28629748
41.

Impact of atopic dermatitis on health-related quality of life and productivity in adults in the United States: An analysis using the National Health and Wellness Survey.

Eckert L, Gupta S, Amand C, Gadkari A, Mahajan P, Gelfand JM.

J Am Acad Dermatol. 2017 Aug;77(2):274-279.e3. doi: 10.1016/j.jaad.2017.04.019. Epub 2017 Jun 9.

42.

Association Between Skin and Aortic Vascular Inflammation in Patients With Psoriasis: A Case-Cohort Study Using Positron Emission Tomography/Computed Tomography.

Dey AK, Joshi AA, Chaturvedi A, Lerman JB, Aberra TM, Rodante JA, Teague HL, Harrington CL, Rivers JP, Chung JH, Kabbany MT, Natarajan B, Silverman JI, Ng Q, Sanda GE, Sorokin AV, Baumer Y, Gerson E, Prussick RB, Ehrlich A, Green LJ, Lockshin BN, Ahlman MA, Playford MP, Gelfand JM, Mehta NN.

JAMA Cardiol. 2017 Sep 1;2(9):1013-1018. doi: 10.1001/jamacardio.2017.1213.

43.

Pediatric Psoriasis Comorbidity Screening Guidelines.

Osier E, Wang AS, Tollefson MM, Cordoro KM, Daniels SR, Eichenfield A, Gelfand JM, Gottlieb AB, Kimball AB, Lebwohl M, Mehta NN, Paller AS, Schwimmer JB, Styne DM, Van Voorhees AS, Tom WL, Eichenfield LF.

JAMA Dermatol. 2017 Jul 1;153(7):698-704. doi: 10.1001/jamadermatol.2017.0499.

PMID:
28514463
44.

Increased prevalence of HCV and hepatic decompensation in adults with psoriasis: a population-based study in the United Kingdom.

Noe MH, Grewal SK, Shin DB, Ogdie A, Takeshita J, Gelfand JM.

J Eur Acad Dermatol Venereol. 2017 Oct;31(10):1674-1680. doi: 10.1111/jdv.14310. Epub 2017 Jun 1.

PMID:
28485831
45.

Risk of venous thromboembolism in patients with psoriatic arthritis, psoriasis and rheumatoid arthritis: a general population-based cohort study.

Ogdie A, Kay McGill N, Shin DB, Takeshita J, Jon Love T, Noe MH, Chiesa Fuxench ZC, Choi HK, Mehta NN, Gelfand JM.

Eur Heart J. 2017 Apr 20. doi: 10.1093/eurheartj/ehx145. [Epub ahead of print]

PMID:
28444172
46.

Development and Validation of an Algorithm to Accurately Identify Atopic Eczema Patients in Primary Care Electronic Health Records from the UK.

Abuabara K, Magyari AM, Hoffstad O, Jabbar-Lopez ZK, Smeeth L, Williams HC, Gelfand JM, Margolis DJ, Langan SM.

J Invest Dermatol. 2017 Aug;137(8):1655-1662. doi: 10.1016/j.jid.2017.03.029. Epub 2017 Apr 18.

47.

Individuals with progranulin haploinsufficiency exhibit features of neuronal ceroid lipofuscinosis.

Ward ME, Chen R, Huang HY, Ludwig C, Telpoukhovskaia M, Taubes A, Boudin H, Minami SS, Reichert M, Albrecht P, Gelfand JM, Cruz-Herranz A, Cordano C, Alavi MV, Leslie S, Seeley WW, Miller BL, Bigio E, Mesulam MM, Bogyo MS, Mackenzie IR, Staropoli JF, Cotman SL, Huang EJ, Gan L, Green AJ.

Sci Transl Med. 2017 Apr 12;9(385). pii: eaah5642. doi: 10.1126/scitranslmed.aah5642.

48.

Psoriasis and comorbid diseases: Implications for management.

Takeshita J, Grewal S, Langan SM, Mehta NN, Ogdie A, Van Voorhees AS, Gelfand JM.

J Am Acad Dermatol. 2017 Mar;76(3):393-403. doi: 10.1016/j.jaad.2016.07.065. Review.

49.

Psoriasis and comorbid diseases: Epidemiology.

Takeshita J, Grewal S, Langan SM, Mehta NN, Ogdie A, Van Voorhees AS, Gelfand JM.

J Am Acad Dermatol. 2017 Mar;76(3):377-390. doi: 10.1016/j.jaad.2016.07.064. Review.

50.

Cause-specific mortality in patients with psoriatic arthritis and rheumatoid arthritis.

Ogdie A, Maliha S, Shin D, Love TJ, Baker J, Jiang Y, Choi H, Gelfand JM.

Rheumatology (Oxford). 2017 Jun 1;56(6):907-911. doi: 10.1093/rheumatology/kew502.

PMID:
28158384

Supplemental Content

Loading ...
Support Center